Kallikrein-kinin in stem cell therapy

doi:10.4252/wjsc.v6.i4.448

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7650)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

378

WORD

176

HTML

3964

Figures (1-2)

597

Tables (1-1)

186

Sum=5301

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1040

Download

1309

Sum=2349

Sep 26, 2014 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Sep 26, 2014; 6(4): 448-457
Published online Sep 26, 2014. doi: 10.4252/wjsc.v6.i4.448

Full Size Figure Download Figure

Figure 2 Kallikrein-kinin enhances the proliferation, viability, migration and function of stem cells. MSC: Mesenchymal stem cell; EPC: Endothelial progenitor cell; MNC: Mononuclear cell; NSC: Neural stem cell.

Citation: Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World J Stem Cells 2014; 6(4): 448-457
URL: https://www.wjgnet.com/1948-0210/full/v6/i4/448.htm
DOI: https://dx.doi.org/10.4252/wjsc.v6.i4.448